Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke J Laffin

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Hypertension|November 14, 2016
Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?Luke J Laffin, George L Bakris
Hypertension (Dallas, Tex. : 1979)|October 26, 2018
Has the Sun Set on Nighttime Dosing in Uncomplicated Hypertension?Luke J Laffin, George L Bakris
Advances in Chronic Kidney Disease|February 24, 2015
Renal denervation for resistant hypertension and beyondLuke J Laffin, George L Bakris
American Journal of Nephrology|July 23, 2018
Beyond Hypertension and Cardio-Renal Syndrome: The Need to Acknowledge and Incorporate Renal Disease in Cardiac Electrophysiology TrialsLuke J Laffin, Marion A Hofmann-Bowman
Current Opinion in Cardiology|March 26, 2026
Aldosterone synthase inhibition in hypertension: an evolving therapeutic strategyRadwan Alkhatib, Taha Hatab, Luke J Laffin
British Journal of Sports Medicine|January 11, 2024
Exercise prescription for the prevention and treatment of arterial hypertension: targeting blood pressure is not necessarily the goalErik H Van Iterson, Luke J Laffin
Cleveland Clinic Journal of Medicine|August 1, 2025
Should I consider single-pill combination antihypertensive therapy for my patient with high blood pressure?Maximilian C Volk, Ahmad Safdar, Luke J Laffin
Journal of Clinical Hypertension (Greenwich, Conn.)|October 24, 2025
In Reply: Time in Target Range, Sex-Specific Effects, and the Path to Clinical IntegrationNeel Agarwal, Julie St John, Luke J Laffin
European Heart Journal|December 17, 2022
Are dietary supplements beneficial in lowering cholesterol? SPORT reflections and the path forwardLuke J Laffin, Dennis Bruemmer, Steven E Nissen
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|February 5, 2023
Newer alternatives for resistant hypertension: Beyond 2022 paradigmsLuke J Laffin, Alexandros Briasoulis, George L Bakris
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Hypertension|November 14, 2016
Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?Luke J Laffin, George L Bakris
Hypertension (Dallas, Tex. : 1979)|October 26, 2018
Has the Sun Set on Nighttime Dosing in Uncomplicated Hypertension?Luke J Laffin, George L Bakris
Advances in Chronic Kidney Disease|February 24, 2015
Renal denervation for resistant hypertension and beyondLuke J Laffin, George L Bakris
American Journal of Nephrology|July 23, 2018
Beyond Hypertension and Cardio-Renal Syndrome: The Need to Acknowledge and Incorporate Renal Disease in Cardiac Electrophysiology TrialsLuke J Laffin, Marion A Hofmann-Bowman
Current Opinion in Cardiology|March 26, 2026
Aldosterone synthase inhibition in hypertension: an evolving therapeutic strategyRadwan Alkhatib, Taha Hatab, Luke J Laffin
British Journal of Sports Medicine|January 11, 2024
Exercise prescription for the prevention and treatment of arterial hypertension: targeting blood pressure is not necessarily the goalErik H Van Iterson, Luke J Laffin
Cleveland Clinic Journal of Medicine|August 1, 2025
Should I consider single-pill combination antihypertensive therapy for my patient with high blood pressure?Maximilian C Volk, Ahmad Safdar, Luke J Laffin
Journal of Clinical Hypertension (Greenwich, Conn.)|October 24, 2025
In Reply: Time in Target Range, Sex-Specific Effects, and the Path to Clinical IntegrationNeel Agarwal, Julie St John, Luke J Laffin
European Heart Journal|December 17, 2022
Are dietary supplements beneficial in lowering cholesterol? SPORT reflections and the path forwardLuke J Laffin, Dennis Bruemmer, Steven E Nissen
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|February 5, 2023
Newer alternatives for resistant hypertension: Beyond 2022 paradigmsLuke J Laffin, Alexandros Briasoulis, George L Bakris
Pageof 9